3HG5 - JenaLib

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 4. PRODUCT BOUND

Authors :   A. I. Guce, N. E. Clark, S. C. Garman

Date :   13 May 09 (Deposition) - 24 Nov 09 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.30

Chains :   Asym./Biol. Unit : A,B

Keywords :   Glycoprotein, Carbohydrate-Binding Protein, Glycosidase, Lysosomal Enzyme, (Beta/Alpha)8 Barrel, Disease Mutation, Disulfide Bond, Hydrolase, Lysosome (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   A. I. Guce, N. E. Clark, E. N. Salgado, D. R. Ivanen, A. A. Kulminskaya, H. Brumer, S. C. Garman
Catalytic Mechanism Of Human Alpha-Galactosidase.
J. Biol. Chem. V. 285 3625 2010
PubMed-ID: 19940122 | Reference-DOI: 10.1074/JBC.M109.060145

Molecule 1 - ALPHA-GALACTOSIDASE A
	Chains	:	A, B
	EC Number	:	3.2.1.22
	Engineered	:	YES
	Expression System	:	HOMO SAPIENS
	Expression System Common	:	HUMAN
	Expression System Taxid	:	9606
	Gene	:	GLA
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	ALPHA-D-GALACTOSIDE GALACTOHYDROLASE, ALPHA-D-GALACTOSIDASE A, MELIBIASE

		1	2
Asymmetric/Biological Unit	:	A	B

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (7, 21)

No.	Name	Count	Type	Full Name
1	ACY	4	Ligand/Ion	ACETIC ACID
2	BMA	2	Ligand/Ion	BETA-D-MANNOSE
3	GAL	1	Ligand/Ion	BETA-D-GALACTOSE
4	GLA	2	Ligand/Ion	ALPHA D-GALACTOSE
5	MAN	1	Ligand/Ion	ALPHA-D-MANNOSE
6	NAG	7	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
7	SO4	4	Ligand/Ion	SULFATE ION

Asymmetric Unit (21, 21)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	ASN A:139 , PHE A:149 , TYR A:173 , CYS A:174 , ASP A:175 , ASN A:179 , HOH A:1179	BINDING SITE FOR RESIDUE NAG A 639
02	AC2	SOFTWARE	ASP A:33 , ASN A:34 , ASN A:192 , NAG A:693 , TRP B:209 , PRO B:210	BINDING SITE FOR RESIDUE NAG A 692
03	AC3	SOFTWARE	ASP A:33 , NAG A:692 , BMA A:694	BINDING SITE FOR RESIDUE NAG A 693
04	AC4	SOFTWARE	NAG A:693	BINDING SITE FOR RESIDUE BMA A 694
05	AC5	SOFTWARE	ASN A:215 , GLU A:218 , GLN A:221 , HOH A:1114 , HOH A:1200 , HOH A:1329	BINDING SITE FOR RESIDUE NAG A 715
06	AC6	SOFTWARE	TRP A:47 , ASP A:92 , ASP A:93 , TYR A:134 , CYS A:142 , LYS A:168 , ASP A:170 , GLU A:203 , ARG A:227 , ASP A:231 , HOH A:1021	BINDING SITE FOR RESIDUE GLA A 801
07	AC7	SOFTWARE	LEU A:32 , ASP A:33 , ARG A:220 , HOH A:1178	BINDING SITE FOR RESIDUE SO4 A 821
08	AC8	SOFTWARE	ARG A:332 , ILE A:367 , ALA A:368 , SER A:371 , ARG A:402	BINDING SITE FOR RESIDUE SO4 A 824
09	AC9	SOFTWARE	SER A:405 , HIS A:406	BINDING SITE FOR RESIDUE ACY A 841
10	BC1	SOFTWARE	GLN A:386 , VAL A:390 , ARG A:392	BINDING SITE FOR RESIDUE ACY A 843
11	BC2	SOFTWARE	ASN B:139 , PHE B:149 , TYR B:173 , HOH B:1168	BINDING SITE FOR RESIDUE NAG B 639
12	BC3	SOFTWARE	ASP B:33 , ASN B:192 , ARG B:196 , NAG B:693	BINDING SITE FOR RESIDUE NAG B 692
13	BC4	SOFTWARE	ASP B:33 , NAG B:692 , BMA B:694	BINDING SITE FOR RESIDUE NAG B 693
14	BC5	SOFTWARE	NAG B:693 , MAN B:695	BINDING SITE FOR RESIDUE BMA B 694
15	BC6	SOFTWARE	ARG B:38 , BMA B:694	BINDING SITE FOR RESIDUE MAN B 695
16	BC7	SOFTWARE	TRP B:47 , ASP B:92 , ASP B:93 , TYR B:134 , CYS B:142 , LYS B:168 , ASP B:170 , GLU B:203 , TYR B:207 , ARG B:227 , ASP B:231 , HOH B:1167	BINDING SITE FOR RESIDUE GLA B 802
17	BC8	SOFTWARE	GLN B:250 , ASP B:255 , LYS B:374	BINDING SITE FOR RESIDUE GAL B 803
18	BC9	SOFTWARE	ARG B:332 , ILE B:367 , ALA B:368 , SER B:371 , ARG B:402	BINDING SITE FOR RESIDUE SO4 B 822
19	CC1	SOFTWARE	ARG B:392 , SER B:405 , HIS B:406	BINDING SITE FOR RESIDUE SO4 B 823
20	CC2	SOFTWARE	GLN B:386 , VAL B:390 , ARG B:392	BINDING SITE FOR RESIDUE ACY B 842
21	CC3	SOFTWARE	ARG B:118 , ARG B:196	BINDING SITE FOR RESIDUE ACY B 844

Asymmetric/Biological Unit

No.	Residues
1	A:52	-	A:94
2	A:56	-	A:63
3	A:142	-	A:172
4	A:202	-	A:223
5	A:378	-	A:382
6	B:52	-	B:94
7	B:56	-	B:63
8	B:142	-	B:172
9	B:202	-	B:223
10	B:378	-	B:382

Asymmetric/Biological Unit

No.	Residues
1	Asn A:379	-	Pro A:380
2	Leu A:388	-	Pro A:389
3	Asn B:379	-	Pro B:380
4	Leu B:388	-	Pro B:389

Asymmetric/Biological Unit (210, 420)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_000431	L	32	P	AGAL_HUMAN	Disease (FD)	---	A/B	L	32	P
002	UniProt	VAR_077369	D	33	G	AGAL_HUMAN	Unclassified (FD)	869312136	A/B	D	33	G
003	UniProt	VAR_000432	N	34	S	AGAL_HUMAN	Disease (FD)	28935192	A/B	N	34	S
004	UniProt	VAR_077370	G	35	E	AGAL_HUMAN	Unclassified (FD)	869312137	A/B	G	35	E
005	UniProt	VAR_000433	G	35	R	AGAL_HUMAN	Disease (FD)	---	A/B	G	35	R
006	UniProt	VAR_077371	L	36	W	AGAL_HUMAN	Disease (FD)	869312138	A/B	L	36	W
007	UniProt	VAR_012364	P	40	L	AGAL_HUMAN	Disease (FD)	---	A/B	P	40	L
008	UniProt	VAR_000434	P	40	S	AGAL_HUMAN	Disease (FD)	104894831	A/B	P	40	S
009	UniProt	VAR_062551	M	42	L	AGAL_HUMAN	Disease (FD)	797044613	A/B	M	42	L
010	UniProt	VAR_077372	M	42	T	AGAL_HUMAN	Disease (FD)	398123201	A/B	M	42	T
011	UniProt	VAR_012365	M	42	V	AGAL_HUMAN	Disease (FD)	---	A/B	M	42	V
012	UniProt	VAR_062552	G	43	R	AGAL_HUMAN	Disease (FD)	---	A/B	G	43	R
013	UniProt	VAR_077373	L	45	P	AGAL_HUMAN	Disease (FD)	---	A/B	L	45	P
014	UniProt	VAR_062553	H	46	P	AGAL_HUMAN	Disease (FD)	---	A/B	H	46	P
015	UniProt	VAR_012367	H	46	R	AGAL_HUMAN	Disease (FD)	398123203	A/B	H	46	R
016	UniProt	VAR_012368	H	46	Y	AGAL_HUMAN	Disease (FD)	---	A/B	H	46	Y
017	UniProt	VAR_012369	W	47	G	AGAL_HUMAN	Disease (FD)	---	A/B	W	47	G
018	UniProt	VAR_076478	W	47	R	AGAL_HUMAN	Disease (FD)	---	A/B	W	47	R
019	UniProt	VAR_077374	E	48	D	AGAL_HUMAN	Disease (FD)	869312254	A/B	E	48	D
020	UniProt	VAR_000435	R	49	L	AGAL_HUMAN	Disease (FD)	---	A/B	R	49	L
021	UniProt	VAR_012370	R	49	P	AGAL_HUMAN	Disease (FD)	398123205	A/B	R	49	P
022	UniProt	VAR_012371	R	49	S	AGAL_HUMAN	Disease (FD)	---	A/B	R	49	S
023	UniProt	VAR_000436	C	52	R	AGAL_HUMAN	Disease (FD)	---	A/B	C	52	R
024	UniProt	VAR_000437	C	52	S	AGAL_HUMAN	Disease (FD)	869312256	A/B	C	52	S
025	UniProt	VAR_000438	C	56	F	AGAL_HUMAN	Disease (FD)	869312258	A/B	C	56	F
026	UniProt	VAR_000439	C	56	G	AGAL_HUMAN	Disease (FD)	28935193	A/B	C	56	G
027	UniProt	VAR_012372	C	56	Y	AGAL_HUMAN	Disease (FD)	869312258	A/B	C	56	Y
028	UniProt	VAR_000440	E	59	K	AGAL_HUMAN	Disease (FD)	---	A/B	E	59	K
029	UniProt	VAR_077375	P	60	L	AGAL_HUMAN	Unclassified (FD)	869312262	A/B	P	60	L
030	UniProt	VAR_077376	I	64	F	AGAL_HUMAN	Disease (FD)	869312139	A/B	I	64	F
031	UniProt	VAR_032290	S	65	T	AGAL_HUMAN	Disease (FD)	104894848	A/B	S	65	T
032	UniProt	VAR_000441	E	66	Q	AGAL_HUMAN	Disease (FD)	28935191	A/B	E	66	Q
033	UniProt	VAR_077377	E	71	G	AGAL_HUMAN	Polymorphism	781927744	A/B	E	71	G
034	UniProt	VAR_000442	M	72	V	AGAL_HUMAN	Disease (FD)	---	A/B	M	72	V
035	UniProt	VAR_077378	G	80	D	AGAL_HUMAN	Unclassified (FD)	781838005	A/B	G	80	D
036	UniProt	VAR_000443	G	85	D	AGAL_HUMAN	Disease (FD)	---	A/B	G	85	D
037	UniProt	VAR_012373	Y	86	C	AGAL_HUMAN	Disease (FD)	---	A/B	Y	86	C
038	UniProt	VAR_077379	Y	86	H	AGAL_HUMAN	Disease (FD)	869312140	A/B	Y	86	H
039	UniProt	VAR_012374	L	89	P	AGAL_HUMAN	Disease (FD)	---	A/B	L	89	P
040	UniProt	VAR_000444	L	89	R	AGAL_HUMAN	Disease (FD)	---	A/B	L	89	R
041	UniProt	VAR_077380	I	91	N	AGAL_HUMAN	Disease (FD)	869312141	A/B	I	91	N
042	UniProt	VAR_012375	I	91	T	AGAL_HUMAN	Disease (FD)	869312141	A/B	I	91	T
043	UniProt	VAR_012376	D	92	H	AGAL_HUMAN	Disease (FD)	---	A/B	D	92	H
044	UniProt	VAR_012377	D	92	Y	AGAL_HUMAN	Disease (FD)	---	A/B	D	92	Y
045	UniProt	VAR_012378	D	93	G	AGAL_HUMAN	Disease (FD)	---	A/B	D	93	G
046	UniProt	VAR_062554	D	93	N	AGAL_HUMAN	Disease (FD)	869312270	A/B	D	93	N
047	UniProt	VAR_012379	C	94	S	AGAL_HUMAN	Disease (FD)	---	A/B	C	94	S
048	UniProt	VAR_012380	C	94	Y	AGAL_HUMAN	Disease (FD)	113173389	A/B	C	94	Y
049	UniProt	VAR_012381	W	95	S	AGAL_HUMAN	Disease (FD)	---	A/B	W	95	S
050	UniProt	VAR_012382	A	97	V	AGAL_HUMAN	Disease (FD)	---	A/B	A	97	V
051	UniProt	VAR_000445	R	100	K	AGAL_HUMAN	Disease (FD)	869312273	A/B	R	100	K
052	UniProt	VAR_012383	R	100	T	AGAL_HUMAN	Disease (FD)	---	A/B	R	100	T
053	UniProt	VAR_000447	R	112	C	AGAL_HUMAN	Disease (FD)	104894834	A/B	R	112	C
054	UniProt	VAR_000448	R	112	H	AGAL_HUMAN	Disease (FD)	372966991	A/B	R	112	H
055	UniProt	VAR_062555	R	112	S	AGAL_HUMAN	Disease (FD)	---	A/B	R	112	S
056	UniProt	VAR_077381	F	113	I	AGAL_HUMAN	Unclassified (FD)	869312142	A/B	F	113	I
057	UniProt	VAR_012384	F	113	L	AGAL_HUMAN	Disease (FD)	869312142	A/B	F	113	L
058	UniProt	VAR_012385	F	113	S	AGAL_HUMAN	Disease (FD)	---	A/B	F	113	S
059	UniProt	VAR_062556	L	120	V	AGAL_HUMAN	Disease (FD)	---	A/B	L	120	V
060	UniProt	VAR_077382	A	121	T	AGAL_HUMAN	Unclassified (FD)	782197638	A/B	A	121	T
061	UniProt	VAR_000450	G	128	E	AGAL_HUMAN	Disease (FD)	---	A/B	G	128	E
062	UniProt	VAR_000451	L	131	P	AGAL_HUMAN	Disease (FD)	869312298	A/B	L	131	P
063	UniProt	VAR_012386	Y	134	S	AGAL_HUMAN	Disease (FD)	---	A/B	Y	134	S
064	UniProt	VAR_062557	A	135	V	AGAL_HUMAN	Disease (FD)	---	A/B	A	135	V
065	UniProt	VAR_012387	G	138	R	AGAL_HUMAN	Disease (FD)	---	A/B	G	138	R
066	UniProt	VAR_012388	C	142	R	AGAL_HUMAN	Disease (FD)	---	A/B	C	142	R
067	UniProt	VAR_000452	C	142	Y	AGAL_HUMAN	Disease (FD)	---	A/B	C	142	Y
068	UniProt	VAR_000453	A	143	P	AGAL_HUMAN	Disease (FD)	104894845	A/B	A	143	P
069	UniProt	VAR_012389	A	143	T	AGAL_HUMAN	Unclassified (FD)	104894845	A/B	A	143	T
070	UniProt	VAR_000454	G	144	V	AGAL_HUMAN	Disease (FD)	---	A/B	G	144	V
071	UniProt	VAR_000455	P	146	S	AGAL_HUMAN	Disease (FD)	28935194	A/B	P	146	S
072	UniProt	VAR_012390	S	148	N	AGAL_HUMAN	Disease (FD)	---	A/B	S	148	N
073	UniProt	VAR_012391	S	148	R	AGAL_HUMAN	Disease (FD)	---	A/B	S	148	R
074	UniProt	VAR_077383	I	154	T	AGAL_HUMAN	Polymorphism	869312143	A/B	I	154	T
075	UniProt	VAR_000456	A	156	T	AGAL_HUMAN	Disease (FD)	28935195	A/B	A	156	T
076	UniProt	VAR_000457	A	156	V	AGAL_HUMAN	Disease (FD)	869312307	A/B	A	156	V
077	UniProt	VAR_012392	W	162	C	AGAL_HUMAN	Disease (FD)	869312311	A/B	W	162	C
078	UniProt	VAR_000458	W	162	R	AGAL_HUMAN	Disease (FD)	28935196	A/B	W	162	R
079	UniProt	VAR_012393	G	163	V	AGAL_HUMAN	Disease (FD)	---	A/B	G	163	V
080	UniProt	VAR_077384	V	164	G	AGAL_HUMAN	Disease (FD)	---	A/B	V	164	G
081	UniProt	VAR_077385	V	164	L	AGAL_HUMAN	Unclassified (FD)	869312144	A/B	V	164	L
082	UniProt	VAR_000459	D	165	V	AGAL_HUMAN	Disease (FD)	---	A/B	D	165	V
083	UniProt	VAR_000460	L	166	V	AGAL_HUMAN	Disease (FD)	---	A/B	L	166	V
084	UniProt	VAR_077386	L	167	Q	AGAL_HUMAN	Disease (FD)	---	A/B	L	167	Q
085	UniProt	VAR_012394	D	170	V	AGAL_HUMAN	Disease (FD)	---	A/B	D	170	V
086	UniProt	VAR_062558	G	171	D	AGAL_HUMAN	Disease (FD)	---	A/B	G	171	D
087	UniProt	VAR_012395	C	172	R	AGAL_HUMAN	Disease (FD)	---	A/B	C	172	R
088	UniProt	VAR_000461	C	172	Y	AGAL_HUMAN	Disease (FD)	869312318	A/B	C	172	Y
089	UniProt	VAR_077387	L	180	F	AGAL_HUMAN	Unclassified (FD)	869312145	A/B	L	180	F
090	UniProt	VAR_012396	G	183	D	AGAL_HUMAN	Disease (FD)	---	A/B	G	183	D
091	UniProt	VAR_077388	M	187	I	AGAL_HUMAN	Disease (FD)	869312146	A/B	M	187	I
092	UniProt	VAR_012397	M	187	V	AGAL_HUMAN	Disease (FD)	869312340	A/B	M	187	V
093	UniProt	VAR_077389	R	196	S	AGAL_HUMAN	Unclassified (FD)	869312147	A/B	R	196	S
094	UniProt	VAR_077390	I	198	T	AGAL_HUMAN	Unclassified (FD)	727503950	A/B	I	198	T
095	UniProt	VAR_062559	S	201	F	AGAL_HUMAN	Disease (FD)	---	A/B	S	201	F
096	UniProt	VAR_000462	C	202	W	AGAL_HUMAN	Disease (FD)	28936082	A/B	C	202	W
097	UniProt	VAR_012398	C	202	Y	AGAL_HUMAN	Disease (FD)	869312344	A/B	C	202	Y
098	UniProt	VAR_077391	W	204	R	AGAL_HUMAN	Disease (FD)	869312148	A/B	W	204	R
099	UniProt	VAR_000463	P	205	T	AGAL_HUMAN	Disease (FD)	397515870	A/B	P	205	T
100	UniProt	VAR_077392	K	213	R	AGAL_HUMAN	Unclassified (FD)	869312149	A/B	K	213	R
101	UniProt	VAR_077393	P	214	L	AGAL_HUMAN	Unclassified (FD)	869312150	A/B	P	214	L
102	UniProt	VAR_000464	N	215	S	AGAL_HUMAN	Disease (FD)	28935197	A/B	N	215	S
103	UniProt	VAR_012400	Y	216	D	AGAL_HUMAN	Disease (FD)	---	A/B	Y	216	D
104	UniProt	VAR_077394	I	219	M	AGAL_HUMAN	Unclassified (FD)	869312151	A/B	I	219	M
105	UniProt	VAR_000465	I	219	N	AGAL_HUMAN	Disease (FD)	---	A/B	I	219	N
106	UniProt	VAR_062560	I	219	T	AGAL_HUMAN	Disease (FD)	---	A/B	I	219	T
107	UniProt	VAR_012401	C	223	G	AGAL_HUMAN	Disease (FD)	869312381	A/B	C	223	G
108	UniProt	VAR_000466	N	224	D	AGAL_HUMAN	Disease (FD)	---	A/B	N	224	D
109	UniProt	VAR_012402	N	224	S	AGAL_HUMAN	Disease (FD)	869312383	A/B	N	224	S
110	UniProt	VAR_012403	W	226	R	AGAL_HUMAN	Disease (FD)	---	A/B	W	226	R
111	UniProt	VAR_077395	R	227	P	AGAL_HUMAN	Disease (FD)	---	A/B	R	227	P
112	UniProt	VAR_000467	R	227	Q	AGAL_HUMAN	Disease (FD)	28935198	A/B	R	227	Q
113	UniProt	VAR_077396	N	228	S	AGAL_HUMAN	Unclassified (FD)	869312152	A/B	N	228	S
114	UniProt	VAR_012404	A	230	T	AGAL_HUMAN	Disease (FD)	---	A/B	A	230	T
115	UniProt	VAR_000468	D	231	N	AGAL_HUMAN	Disease (FD)	---	A/B	D	231	N
116	UniProt	VAR_062561	D	234	E	AGAL_HUMAN	Disease (FD)	---	A/B	D	234	E
117	UniProt	VAR_012405	S	235	C	AGAL_HUMAN	Disease (FD)	797044746	A/B	S	235	C
118	UniProt	VAR_012406	W	236	C	AGAL_HUMAN	Disease (FD)	869312386	A/B	W	236	C
119	UniProt	VAR_012407	W	236	L	AGAL_HUMAN	Disease (FD)	---	A/B	W	236	L
120	UniProt	VAR_012408	I	242	N	AGAL_HUMAN	Disease (FD)	---	A/B	I	242	N
121	UniProt	VAR_077397	I	242	V	AGAL_HUMAN	Unclassified (FD)	---	A/B	I	242	V
122	UniProt	VAR_077398	L	243	F	AGAL_HUMAN	Unclassified (FD)	397515874	A/B	L	243	F
123	UniProt	VAR_012409	D	244	H	AGAL_HUMAN	Disease (FD)	---	A/B	D	244	H
124	UniProt	VAR_000469	D	244	N	AGAL_HUMAN	Disease (FD)	727503948	A/B	D	244	N
125	UniProt	VAR_077399	S	247	P	AGAL_HUMAN	Disease (FD)	869312393	A/B	S	247	P
126	UniProt	VAR_077400	N	249	K	AGAL_HUMAN	Unclassified (FD)	---	A/B	N	249	K
127	UniProt	VAR_077401	I	253	T	AGAL_HUMAN	Unclassified (FD)	727505292	A/B	I	253	T
128	UniProt	VAR_077402	V	254	A	AGAL_HUMAN	Unclassified (FD)	869312153	A/B	V	254	A
129	UniProt	VAR_012410	G	258	R	AGAL_HUMAN	Disease (FD)	---	A/B	G	258	R
130	UniProt	VAR_012411	P	259	L	AGAL_HUMAN	Disease (FD)	869312399	A/B	P	259	L
131	UniProt	VAR_012412	P	259	R	AGAL_HUMAN	Disease (FD)	869312399	A/B	P	259	R
132	UniProt	VAR_012413	G	260	A	AGAL_HUMAN	Disease (FD)	---	A/B	G	260	A
133	UniProt	VAR_012414	G	261	D	AGAL_HUMAN	Disease (FD)	---	A/B	G	261	D
134	UniProt	VAR_077403	W	262	R	AGAL_HUMAN	Disease (FD)	869312154	A/B	W	262	R
135	UniProt	VAR_012415	N	263	S	AGAL_HUMAN	Disease (FD)	869312404	A/B	N	263	S
136	UniProt	VAR_000471	D	264	V	AGAL_HUMAN	Disease (FD)	28935486	A/B	D	264	V
137	UniProt	VAR_062562	D	264	Y	AGAL_HUMAN	Disease (FD)	190347120	A/B	D	264	Y
138	UniProt	VAR_012416	P	265	R	AGAL_HUMAN	Disease (FD)	---	A/B	P	265	R
139	UniProt	VAR_032291	D	266	H	AGAL_HUMAN	Disease (FD)	---	A/B	D	266	H
140	UniProt	VAR_012418	D	266	N	AGAL_HUMAN	Disease (FD)	869312407	A/B	D	266	N
141	UniProt	VAR_000472	D	266	V	AGAL_HUMAN	Disease (FD)	28935487	A/B	D	266	V
142	UniProt	VAR_012419	M	267	I	AGAL_HUMAN	Disease (FD)	730880451	A/B	M	267	I
143	UniProt	VAR_000473	V	269	A	AGAL_HUMAN	Disease (FD)	28935488	A/B	V	269	A
144	UniProt	VAR_077404	V	269	G	AGAL_HUMAN	Disease (FD)	---	A/B	V	269	G
145	UniProt	VAR_000474	N	272	K	AGAL_HUMAN	Disease (FD)	---	A/B	N	272	K
146	UniProt	VAR_032292	N	272	S	AGAL_HUMAN	Disease (FD)	28935495	A/B	N	272	S
147	UniProt	VAR_062563	S	276	G	AGAL_HUMAN	Disease (FD)	869312432	A/B	S	276	G
148	UniProt	VAR_000475	Q	279	E	AGAL_HUMAN	Disease (FD)	28935485	A/B	Q	279	E
149	UniProt	VAR_012420	Q	279	H	AGAL_HUMAN	Disease (FD)	---	A/B	Q	279	H
150	UniProt	VAR_012421	Q	280	H	AGAL_HUMAN	Disease (FD)	---	A/B	Q	280	H
151	UniProt	VAR_000476	M	284	T	AGAL_HUMAN	Disease (FD)	---	A/B	M	284	T
152	UniProt	VAR_062564	A	285	P	AGAL_HUMAN	Disease (FD)	---	A/B	A	285	P
153	UniProt	VAR_012422	W	287	C	AGAL_HUMAN	Disease (FD)	---	A/B	W	287	C
154	UniProt	VAR_012423	W	287	G	AGAL_HUMAN	Disease (FD)	---	A/B	W	287	G
155	UniProt	VAR_000477	A	288	D	AGAL_HUMAN	Disease (FD)	869312437	A/B	A	288	D
156	UniProt	VAR_012424	I	289	F	AGAL_HUMAN	Disease (FD)	---	A/B	I	289	F
157	UniProt	VAR_077405	I	289	V	AGAL_HUMAN	Polymorphism	140329381	A/B	I	289	V
158	UniProt	VAR_012425	M	296	I	AGAL_HUMAN	Disease (FD)	104894846	A/B	M	296	I
159	UniProt	VAR_000478	M	296	V	AGAL_HUMAN	Disease (FD)	104894830	A/B	M	296	V
160	UniProt	VAR_000479	S	297	F	AGAL_HUMAN	Disease (FD)	28935489	A/B	S	297	F
161	UniProt	VAR_012426	N	298	H	AGAL_HUMAN	Disease (FD)	---	A/B	N	298	H
162	UniProt	VAR_000480	N	298	K	AGAL_HUMAN	Disease (FD)	---	A/B	N	298	K
163	UniProt	VAR_012427	N	298	S	AGAL_HUMAN	Disease (FD)	---	A/B	N	298	S
164	UniProt	VAR_062565	L	300	F	AGAL_HUMAN	Disease (FD)	---	A/B	L	300	F
165	UniProt	VAR_000481	R	301	Q	AGAL_HUMAN	Disease (FD)	104894828	A/B	R	301	Q
166	UniProt	VAR_077406	A	309	V	AGAL_HUMAN	Unclassified (FD)	869312155	A/B	A	309	V
167	UniProt	VAR_077407	D	313	N	AGAL_HUMAN	Polymorphism	---	A/B	D	313	N
168	UniProt	VAR_000482	D	313	Y	AGAL_HUMAN	Disease (FD)	28935490	A/B	D	313	Y
169	UniProt	VAR_077408	D	315	N	AGAL_HUMAN	Unclassified (FD)	869312156	A/B	D	315	N
170	UniProt	VAR_077409	V	316	A	AGAL_HUMAN	Unclassified (FD)	869312157	A/B	V	316	A
171	UniProt	VAR_000483	V	316	E	AGAL_HUMAN	Disease (FD)	---	A/B	V	316	E
172	UniProt	VAR_077410	I	317	S	AGAL_HUMAN	Disease (FD)	869312158	A/B	I	317	S
173	UniProt	VAR_012430	N	320	K	AGAL_HUMAN	Disease (FD)	---	A/B	N	320	K
174	UniProt	VAR_012431	N	320	Y	AGAL_HUMAN	Disease (FD)	---	A/B	N	320	Y
175	UniProt	VAR_012432	Q	321	E	AGAL_HUMAN	Disease (FD)	730880439	A/B	Q	321	E
176	UniProt	VAR_077411	P	323	R	AGAL_HUMAN	Unclassified (FD)	869312159	A/B	P	323	R
177	UniProt	VAR_000484	Q	327	K	AGAL_HUMAN	Disease (FD)	28935491	A/B	Q	327	K
178	UniProt	VAR_077412	Q	327	L	AGAL_HUMAN	Disease (FD)	869312160	A/B	Q	327	L
179	UniProt	VAR_077413	Q	327	R	AGAL_HUMAN	Disease (FD)	869312160	A/B	Q	327	R
180	UniProt	VAR_000486	G	328	A	AGAL_HUMAN	Disease (FD)	28935492	A/B	G	328	A
181	UniProt	VAR_000485	G	328	R	AGAL_HUMAN	Disease (FD)	104894832	A/B	G	328	R
182	UniProt	VAR_062566	G	328	V	AGAL_HUMAN	Disease (FD)	---	A/B	G	328	V
183	UniProt	VAR_077414	Q	330	R	AGAL_HUMAN	Unclassified (FD)	869312161	A/B	Q	330	R
184	UniProt	VAR_062567	E	338	K	AGAL_HUMAN	Disease (FD)	---	A/B	E	338	K
185	UniProt	VAR_012433	W	340	R	AGAL_HUMAN	Disease (FD)	---	A/B	W	340	R
186	UniProt	VAR_012434	E	341	K	AGAL_HUMAN	Disease (FD)	869312214	A/B	E	341	K
187	UniProt	VAR_077415	R	342	P	AGAL_HUMAN	Disease (FD)	---	A/B	R	342	P
188	UniProt	VAR_000487	R	342	Q	AGAL_HUMAN	Disease (FD)	28935493	A/B	R	342	Q
189	UniProt	VAR_077416	A	352	G	AGAL_HUMAN	Unclassified (FD)	869312162	A/B	A	352	G
190	UniProt	VAR_077417	R	356	P	AGAL_HUMAN	Disease (FD)	869312163	A/B	R	356	P
191	UniProt	VAR_062568	R	356	Q	AGAL_HUMAN	Disease (FD)	869312163	A/B	R	356	Q
192	UniProt	VAR_000488	R	356	W	AGAL_HUMAN	Disease (FD)	104894827	A/B	R	356	W
193	UniProt	VAR_062569	E	358	A	AGAL_HUMAN	Disease (FD)	---	A/B	E	358	A
194	UniProt	VAR_000489	E	358	K	AGAL_HUMAN	Disease (FD)	797044774	A/B	E	358	K
195	UniProt	VAR_062570	G	360	C	AGAL_HUMAN	Disease (FD)	782598150	A/B	G	360	C
196	UniProt	VAR_077418	G	360	S	AGAL_HUMAN	Disease (FD)	---	A/B	G	360	S
197	UniProt	VAR_000491	G	361	R	AGAL_HUMAN	Disease (FD)	28935494	A/B	G	361	R
198	UniProt	VAR_012435	R	363	H	AGAL_HUMAN	Disease (FD)	111422676	A/B	R	363	H
199	UniProt	VAR_012436	G	373	D	AGAL_HUMAN	Disease (FD)	869312227	A/B	G	373	D
200	UniProt	VAR_012437	G	373	S	AGAL_HUMAN	Disease (FD)	727504348	A/B	G	373	S
201	UniProt	VAR_077419	G	375	A	AGAL_HUMAN	Unclassified (FD)	869312164	A/B	G	375	A
202	UniProt	VAR_012438	A	377	D	AGAL_HUMAN	Disease (FD)	---	A/B	A	377	D
203	UniProt	VAR_012439	C	378	Y	AGAL_HUMAN	Disease (FD)	---	A/B	C	378	Y
204	UniProt	VAR_077420	R	392	S	AGAL_HUMAN	Unclassified (FD)	869312165	A/B	R	392	S
205	UniProt	VAR_000493	F	396	Y	AGAL_HUMAN	Unclassified	---	A/B	F	396	Y
206	UniProt	VAR_077421	W	399	S	AGAL_HUMAN	Unclassified (FD)	782449839	A/B	W	399	S
207	UniProt	VAR_012440	P	409	A	AGAL_HUMAN	Disease (FD)	---	A/B	P	409	A
208	UniProt	VAR_012441	P	409	T	AGAL_HUMAN	Disease (FD)	---	A/B	P	409	T
209	UniProt	VAR_032293	T	410	A	AGAL_HUMAN	Disease (FD)	104894852	A/B	T	410	A
210	UniProt	VAR_062571	L	414	S	AGAL_HUMAN	Disease (FD)	---	A/B	L	414	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (1, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	ALPHA_GALACTOSIDASE	PS00512	Alpha-galactosidase signature.	AGAL_HUMAN	85-101	2	A:85-101 B:85-101

Asymmetric/Biological Unit (7, 14)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000218516	1a	ENSE00000674005	X:100662913-100662698	216	AGAL_HUMAN	1-65	65	2	A:32-65 B:32-65	34 34
1.2	ENST00000218516	2	ENSE00000674004	X:100658973-100658799	175	AGAL_HUMAN	65-123	59	2	A:65-123 B:65-123	59 59
1.3b	ENST00000218516	3b	ENSE00000674003	X:100656797-100656620	178	AGAL_HUMAN	124-183	60	2	A:124-183 B:124-183	60 60
1.5b	ENST00000218516	5b	ENSE00000674002	X:100655745-100655654	92	AGAL_HUMAN	183-213	31	2	A:183-213 B:183-213	31 31
1.7c	ENST00000218516	7c	ENSE00000674001	X:100653934-100653773	162	AGAL_HUMAN	214-267	54	2	A:214-267 B:214-267	54 54
1.7f	ENST00000218516	7f	ENSE00000673999	X:100653555-100653358	198	AGAL_HUMAN	268-333	66	2	A:268-333 B:268-333	66 66
1.8b	ENST00000218516	8b	ENSE00001826038	X:100653087-100652791	297	AGAL_HUMAN	334-429	96	2	A:334-421 B:334-422	88 89

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:390
 aligned with AGAL_HUMAN | P06280 from UniProtKB/Swiss-Prot  Length:429

    Alignment length:390
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421
           AGAL_HUMAN    32 LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTM 421
               SCOP domains d3hg5a1 A:32-323 Melibiase                                                                                                                                                                                                                                                                          d3hg5a2 A:324-421 Melibiase                                                                        SCOP domains
               CATH domains 3hg5A01 A:32-324 Aldolase class I                                                                                                                                                                                                                                                                    3hg5A02 A:325-421 Golgi alpha-mannosidase II                                                      CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ..........eeeehhhhhh.............hhhhhhhhhhhhhhhhhhhhh..eee........................hhhhhhhhhhhhh..eeeeeee..............hhhhhhhhhhhhh..eeeee.....hhhhhhhhhhhhhhhhhhhh...eeeehhhhhhh.....hhhhhhhhh.eee.......hhhhhhhhhhhhhhhhhhhh.......eee...........hhhhhhhhhhhhhhh...eee.......hhhhhhhhhhhhhhhhhh.......eeeeee..eeeeeee.hhh.eeeeeee.......eeeeee.hhhhhhh....eeeeeeee...eeeeeee...eeeeee....eeeeeeee.. Sec.struct. author
             SAPs(SNPs) (1) PGSEW---L-LR-PPGDL--R---F--KL---FTQ----GV-------D----DC--P-NHGSS-V--K-----------CI------VT------E--P--SV--R---RPV-S-N-----T-T-----CVGVVQ--VDR-------F--D---I--------S-T--FW-RT-------RLSD--M---GD-RPS-TN--ECC-----NFH--P-K---TA---RLADRSVRHI-A--K---G--EH---TP-CDF------IFH-FQ-------V---N-NAS--KE-R---KA-R-------K-RKP---------G---P-A-CR-H---------D-A-DY-------------S---Y--S---------AA---S------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---R----S-T---RR-P--S---G-----------------------------H--R-TYNY-----T-----------HL----------------------------YT----R-------V-----R-L-------Y--------------V--------------Y----------------N----S--Q--------L-----V-N--------------R----Y-N--G--S------H-------G-V------V-K--------------Y--E---Y------LR-------------Q-------------Q-K-S------------S-----------------------------------T------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------V---Y--S------Y-------------------------------------------------------SS---------------------------------------------------------------------------------------------------------T----------------------------------------------V-------------------------------S----------------------------RV---------------------------W----------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------ALPHA_GALACTOSIDA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a  PDB: A:32-65           ----------------------------------------------------------Exon 1.3b  PDB: A:124-183 UniProt: 124-183                  ------------------------------Exon 1.7c  PDB: A:214-267 UniProt: 214-267            Exon 1.7f  PDB: A:268-333 UniProt: 268-333                        Exon 1.8b  PDB: A:334-421 UniProt: 334-429 [INCOMPLETE]                                  Transcript 1 (1)
           Transcript 1 (2) ---------------------------------Exon 1.2  PDB: A:65-123 UniProt: 65-123                    -----------------------------------------------------------Exon 1.5b  PDB: A:183-213      ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 3hg5 A  32 LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTM 421
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421

Chain B from PDB  Type:PROTEIN  Length:391
 aligned with AGAL_HUMAN | P06280 from UniProtKB/Swiss-Prot  Length:429

    Alignment length:391
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421 
           AGAL_HUMAN    32 LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQ 422
               SCOP domains d3hg5b1 B:32-323 Melibiase                                                                                                                                                                                                                                                                          d3hg5b2 B:324-422 Melibiase                                                                         SCOP domains
               CATH domains 3hg5B01 B:32-324 Aldolase class I                                                                                                                                                                                                                                                                    3hg5B02 B:325-422 Golgi alpha-mannosidase II                                                       CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..........eeeehhhhhh.............hhhhhhhhhhhhhhhhhhhhh..eee........................hhhhhhhhhhhhh..eeeeeee..............hhhhhhhhhhhhh..eeeee.....hhhhhhhhhhhhhhhhhh.....eeee............hhhhhhhhh.eee.......hhhhhhhhhhhhhhhhhhhh.......eee...........hhhhhhhhhhhhhhh...eee.......hhhhhhhhhhhhhhhhhh.......eeeeee..eeeeeee.hhh.eeeeeee.......eeeeee.hhhhhhh....eeeeeeee...eeeeeee...eeeeee....eeeeeeeee.. Sec.struct. author
             SAPs(SNPs) (1) PGSEW---L-LR-PPGDL--R---F--KL---FTQ----GV-------D----DC--P-NHGSS-V--K-----------CI------VT------E--P--SV--R---RPV-S-N-----T-T-----CVGVVQ--VDR-------F--D---I--------S-T--FW-RT-------RLSD--M---GD-RPS-TN--ECC-----NFH--P-K---TA---RLADRSVRHI-A--K---G--EH---TP-CDF------IFH-FQ-------V---N-NAS--KE-R---KA-R-------K-RKP---------G---P-A-CR-H---------D-A-DY-------------S---Y--S---------AA---S-------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---R----S-T---RR-P--S---G-----------------------------H--R-TYNY-----T-----------HL----------------------------YT----R-------V-----R-L-------Y--------------V--------------Y----------------N----S--Q--------L-----V-N--------------R----Y-N--G--S------H-------G-V------V-K--------------Y--E---Y------LR-------------Q-------------Q-K-S------------S-----------------------------------T------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------V---Y--S------Y-------------------------------------------------------SS---------------------------------------------------------------------------------------------------------T----------------------------------------------V-------------------------------S----------------------------RV---------------------------W------------------------------------------------------------------ SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------ALPHA_GALACTOSIDA--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a  PDB: B:32-65           ----------------------------------------------------------Exon 1.3b  PDB: B:124-183 UniProt: 124-183                  ------------------------------Exon 1.7c  PDB: B:214-267 UniProt: 214-267            Exon 1.7f  PDB: B:268-333 UniProt: 268-333                        Exon 1.8b  PDB: B:334-422 UniProt: 334-429 [INCOMPLETE]                                   Transcript 1 (1)
           Transcript 1 (2) ---------------------------------Exon 1.2  PDB: B:65-123 UniProt: 65-123                    -----------------------------------------------------------Exon 1.5b  PDB: B:183-213      ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 3hg5 B  32 LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQ 422
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: All beta proteins (24004)

Fold: Glycosyl hydrolase domain (397)

Superfamily: Glycosyl hydrolase domain (397)

Family: alpha-Amylases, C-terminal beta-sheet domain (272)

Protein domain: Melibiase (21)

Human (Homo sapiens) [TaxId: 9606] (16)

1a	d3hg5a2	A:324-421
1b	d3hg5b2	B:324-422

Class: Alpha and beta proteins (a/b) (23833)

Fold: TIM beta/alpha-barrel (3956)

Superfamily: (Trans)glycosidases (1191)

Family: Amylase, catalytic domain (385)

Protein domain: Melibiase (21)

Human (Homo sapiens) [TaxId: 9606] (16)

2a	d3hg5a1	A:32-323
2b	d3hg5b1	B:32-323

Asymmetric/Biological Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: Alpha-Beta Barrel (2994)

Topology: TIM Barrel (2806)

Homologous Superfamily: Aldolase class I (887)

Human (Homo sapiens) (78)

1a	3hg5A01	A:32-324
1b	3hg5B01	B:32-324

Class: Mainly Beta (13760)

Architecture: Sandwich (5577)

Topology: Immunoglobulin-like (3897)

Homologous Superfamily: Golgi alpha-mannosidase II (346)

Human (Homo sapiens) (76)

2a	3hg5A02	A:325-421
2b	3hg5B02	B:325-422

(no "Pfam Domain" information available for 3HG5)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A,B (AGAL_HUMAN | P06280)

molecular function
	GO:0004557	alpha-galactosidase activity	Catalysis of the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-D-galactosides, including galactose oligosaccharides, galactomannans and galactohydrolase.
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0016936	galactoside binding	Interacting selectively and non-covalently with any glycoside in which the sugar group is galactose.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016798	hydrolase activity, acting on glycosyl bonds	Catalysis of the hydrolysis of any glycosyl bond.
	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	Catalysis of the hydrolysis of any O-glycosyl bond.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
	GO:0052692	raffinose alpha-galactosidase activity	Catalysis of the reaction: raffinose + H2O = alpha-D-galactose + sucrose.
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
biological process
	GO:0005975	carbohydrate metabolic process	The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.
	GO:0046479	glycosphingolipid catabolic process	The chemical reactions and pathways resulting in the breakdown of glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.
	GO:0006687	glycosphingolipid metabolic process	The chemical reactions and pathways involving glycosphingolipids, any compound with residues of sphingoid and at least one monosaccharide.
	GO:0046477	glycosylceramide catabolic process	The chemical reactions and pathways resulting in the breakdown of glycosylceramides, any compound formed by the replacement of the glycosidic hydroxyl group of a cyclic form of a monosaccharide (or derivative) by a ceramide group.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
	GO:0045019	negative regulation of nitric oxide biosynthetic process	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
	GO:0051001	negative regulation of nitric-oxide synthase activity	Any process that stops or reduces the activity of the enzyme nitric-oxide synthase.
	GO:0009311	oligosaccharide metabolic process	The chemical reactions and pathways involving oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
cellular component
	GO:0005794	Golgi apparatus	A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0043202	lysosomal lumen	The volume enclosed within the lysosomal membrane.
	GO:0005764	lysosome	A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		ACY	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		BMA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GAL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GLA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MAN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		SO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]
		CC1	[ RasMol ]	+environment [ RasMol ]
		CC2	[ RasMol ]	+environment [ RasMol ]
		CC3	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Asn A:379 - Pro A:380	[ RasMol ]
		Asn B:379 - Pro B:380	[ RasMol ]
		Leu A:388 - Pro A:389	[ RasMol ]
		Leu B:388 - Pro B:389	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	3hg5
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	AGAL_HUMAN \| P06280
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.2.1.22
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	301500
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	AGAL_HUMAN \| P06280
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1r46
1r47
3hg2	HUMAN ALPHA-GALACTOSIDASE MECHANISM 1. EMPTY ACTIVE SITE
3hg3	HUMAN ALPHA-GALACTOSIDASE MECHANISM 2. SUBSTRATE BOUND
3hg4	HUMAN ALPHA-GALACTOSIDASE MECHANISM 3. COVALENT INTERMEDIATE

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (7, 21)

Sites (21, 21)

SS Bonds (10, 10)

Cis Peptide Bonds (4, 4)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (210, 420)

PROSITE Motifs (1, 2)

Exons (7, 14)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 4)

CATH Domains (2, 4)

Pfam Domains (0, 0)

Gene Ontology (24, 24)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File